168
Views
17
CrossRef citations to date
0
Altmetric
Research Article

Accuracy Assessment of the Dinamap ProCare 400 in Pregnancy and Preeclampsia

, , &
Pages 198-205 | Published online: 01 Apr 2010
 

Abstract

Objective. To assess the accuracy of the Dinamap ProCare 400 in pregnancy and preeclampsia, according to the British Hypertension Society protocol. Methods. Ethical approval was obtained. Forty-five women were recruited at two large teaching hospitals. Nine sequential same arm measurements were taken from each woman alternating between the Dinamap and mercury sphygmomanometry. Results. The device achieved an A/A grade (pregnancy) and an A/B grade (preeclampsia). Mean difference (SD) were 1.1(5.8)/0.1(5.7) mmHg (pregnancy) and –0.5(5.4)/0.9(9.5) mmHg (preeclampsia) for systolic/diastolic. Conclusion. The Dinamap ProCare 400 is recommended for use in pregnancy and has good accuracy in preeclampsia, although caution is still advised.

ACKNOWLEDGMENTS

We would like to thank the staff and patients of the antenatal wards and clinics at Groote Schuur Hospital and St Thomas' Hospital for their invaluable contribution to this study. GE Medical provided three devices on loan to be assessed according to the protocol as well as funding for one observer.

Declaration of Interest: The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.